Rabeprazole Sodium
Product Images NDC 45865-269

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 45865-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

269 (45865 269)

Label for Rabeprazole Sodium DR Tablets 20 mg, generic for Aciphex, distributed by Medsource Pharmaceuticals. The label includes dosage information, manufacturer Rubicon Research Ltd. (India), and a count of 30 tablets per container. Additional details on patient log and administration instructions are visible on a peelable strip.*

FDA Label Image

Structural Image (Rabeprazole Dr Tablet 01)

Chemical structure of rabeprazole sodium showing its molecular framework with heterocyclic rings, sodium atom, and functional groups including methoxy and sulfoxide moieties.*

FDA Label Image

Figure 2: Mean Daytime Heartburn Scores Rab-usa-2 (Rabeprazole Dr Tablet 02)

A line graph comparing mean heartburn scores over a 28-day study period among three groups: placebo, RAB 10 mg, and RAB 20 mg. The x-axis shows study days ranging from -14 to 28, with day 0 marked, and the y-axis represents mean heartburn scores from 0 (none) to 4 (very severe). The graph illustrates trends before and after treatment start.*

FDA Label Image

Figure 3: Mean Nighttime Heartburn Scores Rab-usa-2 (Rabeprazole Dr Tablet 03)

This line graph depicts mean heartburn scores over a study period of approximately 42 days, including 14 days before and 28 days after study day 0. It compares three groups: placebo, RAB 10 mg, and RAB 20 mg, with heartburn severity scored from 0 (none) to 4 (very severe).*

FDA Label Image

Figure 4: Mean Daytime Heartburn Scores Rab-usa-3 (Rabeprazole Dr Tablet 04)

A line graph comparing mean heartburn scores over time between a placebo group (n=58) and a RABEPRAZOLE SODIUM 20 mg group (n=59). The X-axis represents study days from -14 to 28, and the Y-axis shows mean heartburn scores ranging from 0 (none) to 4 (very severe). The graph visually demonstrates differences in symptom severity over the study period.*

FDA Label Image

Figure 5: Mean Nighttime Heartburn Scores Rab-usa-3 (Rabeprazole Dr Tablet 05)

A line graph comparing mean heartburn scores over a 28-day study period for two groups: 58 subjects taking placebo and 59 subjects taking RAB 20 mg. The x-axis shows study days from -14 to 28, and the y-axis shows heartburn scores from 0 (none) to 4 (very severe). The graph depicts lower mean scores for the RAB 20 mg group after day 0 compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.